Literature DB >> 8875173

Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease).

P De Leyn1, P Schoonooghe, G Deneffe, D Van Raemdonck, W Coosemans, J Vansteenkiste, T Lerut.   

Abstract

OBJECTIVE: Although the results after surgery for N2 disease are disappointing, there seems to be a subgroup of patients which may benefit from primary resection. These patients have clinically unrecognized N2 involvement that is discovered only at the time of thoracotomy (unsuspected or unforeseen N2 disease). It was the aim of this retrospective study to analyze the survival after resection for unforeseen N2 disease and to evaluate different prognostic factors. We were interested to see whether our strategy of rigorous staging of the mediastinum with mediastinoscopy or anterior mediastinotomy had an effect on the resectability rate and survival of unsuspected N2 disease.
METHODS: Between 1985 and 1990, 859 patients with potentially operable non-small cell lung cancer were referred to our surgical department. Despite rigorous preoperative staging with computed tomography scan and cervical mediastinoscopy and/or anterior mediastinotomy, 103 patients (14.5%) had unsuspected N2 disease at thoracotomy. The tumor could be completely resected in 90 patients (87.5%).
RESULTS: The 5-year survival after complete resection was 22%. Histology of the tumor, number of involved levels and extent of nodal disease had no effect on survival.
CONCLUSION: We conclude that resection is justified in patients with unforeseen N2 disease. Rigorous staging of the mediastinum by cervical mediastinoscopy or anterior mediastinotomy results in a high resectability rate and avoids unnecessary thoracotomies. Mediastinoscopy plays a central role in the staging of patients with carcinoma of the lung.

Entities:  

Mesh:

Year:  1996        PMID: 8875173     DOI: 10.1016/s1010-7940(96)80380-0

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  11 in total

Review 1.  Oncology imaging: nodal spread-intrathoracic nodes.

Authors:  J A Verschakelen; P de Leyn; J Bogaert; A L Baert
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

2.  Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer.

Authors:  Paul J Speicher; Zachary W Fitch; Brian C Gulack; Chi-Fu J Yang; Betty C Tong; David H Harpole; Thomas A D'Amico; Mark F Berry; Matthew G Hartwig
Journal:  Ann Thorac Surg       Date:  2016-07-29       Impact factor: 4.330

3.  Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.

Authors:  Chi-Fu Jeffrey Yang; Arvind Kumar; Brian C Gulack; Michael S Mulvihill; Matthew G Hartwig; Xiaofei Wang; Thomas A D'Amico; Mark F Berry
Journal:  J Thorac Cardiovasc Surg       Date:  2015-12-21       Impact factor: 5.209

Review 4.  Controversies regarding T status and N status for non-small cell lung cancer.

Authors:  Yanli Mo; Jiayin Peng; Wenmei Su; Xinggui Chen; Aibing Wu; Jinmei Li; Zhixiong Yang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  Preoperative concurrent radiochemotherapy and surgery for stage IIIA non-small cell lung cancer.

Authors:  Min Kyu Kang; Yong Chan Ahn; Do Hoon Lim; Keunchil Park; Joon Oh Park; Young Mog Shim; Jhingook Kim; Kwhanmien Kim
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

6.  Long term and disease-free survival following surgical resection of occult N2 lung cancer.

Authors:  Bilal H Kirmani; Sara Volpi; Giuseppe Aresu; Adam Peryt; Thida Win; Aman S Coonar
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

7.  Preoperative Risk Factors for Pathologic N2 Metastasis in Positron Emission Tomography-Computed Tomography-Diagnosed N0-1 Non-Small Cell Lung Cancer.

Authors:  Tae-Hong Yoon; Chul-Ho Lee; Ki-Sung Park; Chi-Hoon Bae; Jun-Woo Cho; Jae-Seok Jang
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2019-08-05

8.  Long term survival of patients with unsuspected n2 disease in non-small cell lung cancer.

Authors:  Deok Heon Lee; Jae Bum Kim; Dong Yoon Keum; Ilseon Hwang; Chang Kwon Park
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-02-06

9.  Endobronchial ultrasound-guided transbronchial needle aspiration in the staging of lung cancer patients.

Authors:  Dariusz Dziedzic; Adam Peryt; Malgorzata Szolkowska; Renata Langfort; Tadeusz Orlowski
Journal:  SAGE Open Med       Date:  2015-10-09

10.  Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non-small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience.

Authors:  Milan Savic; Milica Kontic; Maja Ercegovac; Jelena Stojsic; Slavisa Bascarevic; Dejan Moskovljevic; Marko Kostic; Radomir Vesovic; Spasoje Popevic; Marija Laban; Jelena Markovic; Dragana Jovanovic
Journal:  Thorac Cancer       Date:  2017-07-03       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.